Mepolizumab is a humanized monoclonal antibody that neutralizes interleukin-5 (IL-5). It is a key research tool for investigating severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis (EGPA), supporting both in vitro mechanistic studies and in vivo preclinical models of eosinophil-driven diseases.
Concentration:
101.3 mg/mL
Molecular Weight:
146.24 kDa
Purity:
98.00% (May vary between batches)
CAS Number:
[196078-29-2]
Target:
IL Receptor,Interleukin
* VAT and and shipping costs not included. Errors and price changes excepted